According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.

Things are going from bad to worse for Sarepta Therapeutics (NASDAQ: SRPT), a biotech focusing on gene therapies. The company's performance over the past six months had already been unimpressive. But ...

Investors have wiped more than $100m from the value of Regal Funds on Monday, with fears that a position in one of its stocks ...

Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its target price lowered by Scotiabank from $105.00 to $80.00 in a ...

Me, a biotech company offering genetic testing through saliva samples, has been facing the threat of closure since 2021. Now, ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

Adaptimmune Therapeutics (NASDAQ:ADAP – Get Free Report) had its price objective cut by stock analysts at Scotiabank from $3.15 to $1.40 in a report issued on Friday,Benzinga reports. The brokerage ...

We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are ...

Why didn’t analysts share the same fear that gripped investors about Sarepta stock? One reason is the known risk of acute liver injury associated with adeno-associated virus vector (AAV)-based gene ...

Maximizing Sale Process and Resolve Liabilities. Company Expects to Continue Business Operations in the Ordinary Course ...

After more than a half-decade, dozens of government hearings and votes, a name change, an ownership change and a special election, the sprawling Redtail Ridge mega-development in Louisville is ...